Zeon Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 5 Months
- Last Filing with ROC 31 Mar 2015
- Open Charges ₹ 3.30 M
- Revenue Growth -58.37%
- Profit Growth -341.31%
- Ebitda 39.37%
- Net Worth -5.73%
- Total Assets 39.20%
About Zeon Pharmaceuticals
Zeon Pharmaceuticals Private Limited (ZPPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 September 2008 and has a history of 16 years and five months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2015. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.30 M.
Surender Kumar and Sachin Pathgotri serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232DL2008PTC182981
-
Company No.
182981
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Sep 2008
-
Date of AGM
30 Sep 2015
-
Date of Balance Sheet
31 Mar 2015
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Zeon Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surender Kumar
|
Director | 08-Sep-2008 | Current |
|
Sachin Pathgotri
|
Director | 08-Sep-2008 | Current |
Financial Performance of Zeon Pharmaceuticals.
Zeon Pharmaceuticals Private Limited, for the financial year ended 2015, experienced significant reduction in revenue, with a 58.37% decrease. The company also saw a substantial fall in profitability, with a 341.31% decrease in profit. The company's net worth dipped by a decrease of 5.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zeon Pharmaceuticals?
In 2015, Zeon Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.30 M
₹0
Charges Breakdown by Lending Institutions
- Punjab National Bank : 0.33 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Mar 2012 | Punjab National Bank | ₹0.40 M | Open |
| 05 Mar 2011 | Punjab National Bank | ₹2.90 M | Open |
How Many Employees Work at Zeon Pharmaceuticals?
Unlock and access historical data on people associated with Zeon Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zeon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zeon Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.